MedTrace Logo

Effect of Prazosin on Neurophysiology and Cognition in Post-Traumatic Stress Disorder (PTSD)

NCT00890643 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2013-09-23

No results posted yet for this study

Summary

In this study, the investigators are looking at how PTSD affects things such as memory, attention, reaction to sounds, eye movements, and heart rate. The investigators are also studying whether a medication called prazosin has an effect on these things.

Conditions

Interventions

DRUG

prazosin hydrochloride

prazosin 1-20 mg/day in divided doses

DRUG

placebo

placebo

Sponsors & Collaborators

Principal Investigators

  • Dorcas J. Dobie, MD · VA Puget Sound Health Care System

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2011-06-30
Completion
2011-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00890643 on ClinicalTrials.gov